Hyperlipidemia and Statins Use for the Risk of New Diagnosed Sarcopenia in Patients with Chronic Kidney: A Population-Based Study

Background: Previous research found that statins, in addition to its efficiency in treating hyperlipidemia, may also incur adverse drug reactions, which mainly include myopathies and abnormalities in liver function. Aim: This study aims to assess the risk for newly onset sarcopenia among patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Min-Hua, Chiu, She-Yu, Chang, Pei-Hsuan, Lai, Yu-Liang, Chen, Pau-Chung, Ho, Wen-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084510/
https://www.ncbi.nlm.nih.gov/pubmed/32110901
http://dx.doi.org/10.3390/ijerph17051494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084510/
https://www.ncbi.nlm.nih.gov/pubmed/32110901
http://dx.doi.org/10.3390/ijerph17051494

Ejemplares similares